Pulse Biosciences, Inc. Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions
Pulse Biosciences, Inc. (PLSE) reported Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions of $255.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-19.
Financial Statements › Notes › Income Taxes › Income Tax Uncertainties
us-gaap:UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions · last filed 2026-02-19
- Pulse Biosciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2025 was $255.00K, a 66.67% increase from fiscal 2024.
- Pulse Biosciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2024 was $153.00K, a 89.51% decline from fiscal 2023.
- Pulse Biosciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2023 was $1.46M.
- Pulse Biosciences, Inc. unrecognized tax benefits, decrease resulting from prior period tax positions for fiscal 2022 was $0.00.
| Period end | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions 12 month |
|---|---|
| 2025-12-31 | $255.00K 10-K · filed 2026-02-19 |
| 2024-12-31 | $153.00K 10-K · filed 2026-02-19 |
| 2023-12-31 | $1.46M 10-K · filed 2025-03-31 |
| 2022-12-31 | $0.00 10-K · filed 2024-03-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |
| NovoCure Ltd (NVCR) | $1.886B | -11.87 |